Global Endometrial Cancer Therapeutics Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 2023 – Market Research Report 2017

Jul 17, 2017

OrbisResearch.com has published new research report on "Global Endometrial Cancer Therapeutics Market Research Report and Forecast to 2017-2023" to its database.

Dallas, United States - July 17, 2017 /MarketersMedia/ —

Endometrial Carcinoma is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, endometrial cancer is also the most common cancer of the female reproductive organs in the US. About 60,050 new cases of cancer of uterus were estimated to be diagnosed during 2016, and about 10,470 women died from cancers of the uterine body during the same year.Early detection of endometrial cancer helps in the selection of proper treatment options. Endometrial Cancer can be treated by one or combination of therapies, such as chemotherapy, radiation therapy, hormone therapy, and surgery. Most of the physicians generally recommend combination treatments because chemotherapy alone has conventionally been deemed ineffective. Furthermore, adjuvant radiation therapy is ideal in patients who have diagnosed with Stage I or II endometrial cancer. Radiation Therapy is also recommended in patients who have undergone the surgery to avoid the relapse of endometrial cancer.

Browse the report: http://www.orbisresearch.com/reports/index/global-endometrial-cancer-therapeutics-market-by-therapy-chemotherapy-hormone-therapy-radiation-therapy-surgery-by-enduser-research-institutes-hospitals-and-clinics-and-pipeline-analysis-outlook-to-2023

According to the RNCOS report entitled “Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023”, the Endometrial Cancer therapeutics market is poised to reach approximately US$ 27 Billion by 2023. In this report, there is in-depthmarket analysis as well as market segmentation of global endometrial cancer therapeutics. The market potential of endometrial cancer therapeutic drugsisestimated considering that these are being tested in clinical trials for endometrial cancer, besides the ones which have already been approved. The depictedendometrial cancer therapeutic drugsare expected to show their complete market potential soon in the coming years.

Furthermore, in this report we have structured the information on epidemiology of endometrial cancer in the world. The report also covers pipeline analysis of endometrial cancer therapeutic drugs at various stages of clinical development that are under research or in collaboration, and those individually being developed by companies. Moreover, our report places an emphasis on the major drivers and challenges, latest trends and developments,as well as strategic collaborations that can impact industry’s growth.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/333581

In the end, the report enlists some of the key players in the Endometrial Cancer Therapeutics market including business overview of each player along with their product and pipeline portfolios, recent developments, and comparative analysis of their strengths and weaknesses.Conclusively, the report will prove to be a complete and comprehensive source of knowledge and analysis for clients and potential investors or debut makers in this industry.

Major Points From The Table Of Contents:
Analyst View
Research Methodology
Endometrial Cancer - Epidemiology & Risk Factors
Endometrial Cancer Therapeutics - An Introduction
Market Dynamics
Endometrial Cancer Therapeutics Market Outlook to 2023
Market Segmentation
Endometrial Cancer Therapeutic Drugs Pipeline Analysis
Trends and Developments
Strategic Mergers & Collaborations in the Endometrial Cancer Therapeutics Industry
Competitive Assessment

Buy the report@http://www.orbisresearch.com/contact/purchase/333581

List of Figures:
Figure 3-1: Estimated Age-specific Incidence & Mortality Rates for Endometrial Cancer, 2016
Figure 4-1: Endometrial Cancer Therapeutic Drugs - Mechanism of Action
Figure 5-1: Global Healthcare Spending (Billion US$), 2015 & 2020
Figure 5-2: Healthcare Spending by Region (Billion US$), 2015 & 2020
Figure 6-1: Global - Endometrial Cancer Therapeutics Market (Billion US$), 2016-2023
Figure 7-1: Global - Endometrial Cancer Therapeutics Market by Therapy (%), 2016
Figure 7-2: Global - Endometrial Cancer Chemotherapy Market (Billion US$), 2016 & 2023
Figure 7-3: Global - Endometrial Cancer Hormone Therapy Market (Billion US$), 2016 & 2023
Figure 7-4: Global - Endometrial Cancer Radiation Therapy Market (Billion US$), 2016 & 2023
Figure 7-5: Global - Endometrial Cancer Surgery Market (Billion US$), 2016 & 2023
Figure 7-6: Global - Endometrial Cancer Therapeutics Market by End Users (%), 2016
Figure 7-7: Global - Endometrial Cancer Therapeutics Market by Research Institutes (Billion US$), 2016 & 2023
Figure 7-8: Global - Endometrial Cancer Therapeutics Market by Hospitals (Billion US$), 2016 & 2023

List of Tables:
Table 6-1: Potential Patients for Endometrial Cancer Therapeutics, 2015, 2020 & 2025
Table 8-1: Industrial Endometrial Cancer Therapeutic Drugs Pipeline
Table 8-2: Research Collaborations Endometrial Cancer Therapeutic Drugs Pipeline
Table 10-1: Strategic Mergers & Collaborations in Endometrial Cancer Therapeutics Industry, 2014-2016
Table 11-1: Top Companies by Endometrial Cancer Therapeutic Drugs in Pipeline (2016)
Table 11-2: Bayer AG - Endometrial Cancer Therapeutic Drugs in Pipeline
Table 11-3: Bayer AG - Key Financials (Million US$), 2014-2016
Table 11-4: F. Hoffman La Roche Ltd. - Endometrial Cancer Therapeutic Drugs in Pipeline
Table 11-5: F. Hoffman La Roche Ltd. - Key Financials (Million US$), 2014-2016

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: [email protected]
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817

Source URL: http://marketersmedia.com/global-endometrial-cancer-therapeutics-market-projections-swot-analysis-risk-analysis-trends-and-forecast-by-2023-market-research-report-2017/217971

For more information, please visit http://www.orbisresearch.com/reports/index/global-endometrial-cancer-therapeutics-market-by-therapy-chemotherapy-hormone-therapy-radiation-therapy-surgery-by-enduser-research-institutes-hospitals-and-clinics-and-pipeline-analysis-outlook-to-2023

Source: MarketersMedia

Release ID: 217971

More News

Oct 1, 2026

Pilot stabs fellow pilot on flight to Israel before passengers intervene to stop attack

TEL AVIV, Israel — A copilot stabbed a captain in an apparent attempt to crash a jetliner as it was flying 174 people to Israel on Wednesday. But passengers burst into the cockpit and wrestled with the attacker even as the plane descended sharply, witnesses and Israel’s government said. The plane made an emergency landing in Saudi Arabia. The shaken passengers from the FlyDubai flight from Dubai to Tel Aviv landed Wednesday evening in Israel on another flight, as onlookers cheered. Israel's emergency services said they treated three passengers with minor injuries. It was not clear what motivated the attack, which led Israel to scramble warplanes amid concerns about a possible hijacking . In a CNN interview aired on Wednesday evening, Israeli Prime Minister Benjamin Netanyahu said the attacker was an Omani national and was being interrogated in Saudi Arabia, where he was arrested. Aviation experts were surprised the plane did not crash after a descent so extreme that most of the rudder was ripped off the tail. “We’re going to die,” passenger Naama Bershadski recalled thinking as

Oct 1, 2026

Second judge blocks Trump's $100,000 fee for new H-1B worker visas

A second federal judge on Wednesday blocked an unprecedented $100,000 fee that US President Donald Trump has imposed on new H-1B visas for highly skilled foreign workers. US District Judge Haywood Gilliam in Oakland, California, ruled that US Citizenship and Immigration Services and the State Department failed to follow necessary rule-making processes before implementing Trump's fee. Gilliam, appointed by then-President Barack Obama, a Democrat, granted a request by a coalition of unions, employers and nonprofits to block the agencies from implementing Trump's fee pending the outcome of a lawsuit they filed in October. The fee was temporarily blocked in June by a federal judge in Boston, ruling in a separate case brought by 20 states. A Boston-based appeals court in July declined to pause that decision. The Department of Homeland Security in August moved to adopt a permanent fee of about $103,000 that, when finalized, will likely be challenged in court. But that will involve different legal issues than lawsuits over the fee set by Trump. These suits have focused on the president's power

Oct 1, 2026

Google announces Gemini 4 flagship AI model after months of delays

SAN FRANCISCO — Alphabet's Google on Wednesday announced a new top-tier artificial intelligence model to anchor its Gemini 4 generation of models in a fresh bid to catch up to rivals Anthropic and OpenAI in the AI race. The new model, "Argon", is larger in size than Google's previous line of advanced "Pro" models, a company spokesperson said. "It's our most performant model yet built for complex workloads, and we see it comparable to frontier models like (OpenAI's) Astra and (Anthropic's) Opus on key coding and cyber benchmarks," the spokesperson said. Google said it was providing the model to select cybersecurity partners and was participating in the Trump administration's voluntary process for pre-release model access. It did not provide a timeline for the model's public release. The model posted better marks than Astra and Opus in terms of self-reported performance on several industry benchmarks, per a company press release. Still, Argon remained behind on certain other metrics, including two of the four coding-related benchmarks Google included in the release. Google no longer plans

Oct 1, 2026

Nearly 1,000 children were abused at three Massachusetts dioceses, state probe finds

BOSTON — More than 270 Catholic clerics sexually abused nearly 1,000 children across three Massachusetts dioceses over decades, according to an investigative report the state's attorney general released on Wednesday. The report provided what Massachusetts Attorney General Andrea Joy Campbell called the first full public accounting of the abuse and institutional failures that allowed it to proliferate for more than half a century at the Catholic dioceses of Fall River, Springfield and Worcester. Most of the abuse detailed in the report occurred before 2002, the year the clergy sex abuse scandal burst onto the international stage due to a Pulitzer Prize-winning report by the Boston Globe on how officials at the Roman Catholic Archdiocese of Boston routinely covered up sex abuse by priests. The state attorney general's investigation documented years of similar issues at the three dioceses in other parts of Massachusetts, which Campbell said knew children were being abused by priests and other clerics. "Too often they protected the reputation of the church rather than protecting children,"

Oct 1, 2026

N. Korea's Kim vows to bring bilateral ties to 'new strategic level' in letter to Xi

North Korean leader Kim Jong-un on Thursday reaffirms his commitment to lifting bilateral relations with China to a "new strategic level" in a letter to Chinese President Xi Jinping marking China's National Day, Pyongyang's state media reported. In the letter for the 77th anniversary of the country's founding, Kim extended "the warmest congratulations and best wishes" to Xi and the Chinese people, the Korean Central News Agency (KCNA) said. Kim noted the two countries marked the 65th anniversary of their friendship treaty this year and are promoting exchanges "in all fields." "The history of the DPRK-China friendship, which was forged at the cost of blood and has been carried forward with genuine comradely friendship, can never be shaken no matter how the international situation may change," he wrote. DPRK stands for the Democratic People's Republic of Korea, the North's official name. It is his country's "steadfast will" to "steadily develop the traditional relations of unity and cooperation" with China, he added. He also referred to his two recent summits with Xi. "I had meaningful meetin

Oct 1, 2026

Why are French students blocking their school entrances?

High schoolers across #France continued to blockade their #schools on Thursday, trying to form a "blocus" at the entrances of their schools in #protest. French Interior Minister Laurent Nuñez said that 625 people, mostly students, had been detained during blockade attempts on Wednesday, noting "an expansion of the movement". But what are they asking for? FRANCE 24's Tanishk Saha explains.

Oct 1, 2026

Israel's Netanyahu says co-pilot tried to crash Tel Aviv-bound plane

PRESS REVIEW – Thursday, October 1: A FlyDubai flight was diverted to Saudi Arabia after the pilot was stabbed by his co-pilot in what the Israeli media are calling a terror attack. The co-pilot was detained by off-duty pilots on board and passengers before making a safe landing in Saudi Arabia. Also in the news, Cornell University's college campus culture is back under scrutiny after a shocking sexual assault claim. Plus, a man learns that Singapore does not take AI slop lightly.

Oct 1, 2026

Four passengers to be awarded for heroism during apparent attempt to crash plane

Three Israeli passengers who stormed the cockpit and a dentist who treated the wounded captain of the flight are being hailed as heroes after Wednesday’s midair emergency.

Oct 1, 2026

You’re supposed to get one free doctor’s visit every year. So why are so many Americans being charged?

After moving to West Virginia last year, Steve Kuo signed up for a new insurance plan that would cost him $500 a month. But there was one upside: He knew he was entitled to a free preventive visit. He wanted to take advantage of it, so he made an appointment at a clinic near his new home. But then when he got there, they asked about his medical history and he mentioned prior kidney problems. When he received a bill a few weeks later, he had been charged twice for the same appointment: Once as that free preventive visit, once as an “office sick visit” because of the kidney conversation. He was flummoxed — and very annoyed, as he shared on social media. “No copayment means no copayment, exactly as stated in the insurance guidelines,” Kuo told me over email. “What is written and agreed upon should be honored.” He is far from alone. On Reddit, I easily found more than a dozen examples in just the past year of people getting a surprise bill for what they thought was going to be a free visit. One woman posted a nearly $1,000 bill she’d received for what she thought was going to be a preventive gynecology visit. Another woman said that she ended up facing roughly $3,000 bills because she was given an ultrasound (which she said she didn’t request) at a preventive visit, and then her blood draw was sent to an out-of-network lab. Another person lamented that they had been billed $170 for an office visit because they had briefly mentioned back stiffness. It’s not supposed to be like this. Americans don’t get much when it comes to our healthcare, but most of us are supposed to be entitled to at least one thing: Once every year, no matter your health insurance, you can go to the doctor with the goal of preventing future health problems by discussing important vaccinations, cancer screenings, and cardiovascular health screenings. The Affordable Care Act made that the law in 2010. But more than 15 years later, people all over the country are walking into their doctor’s office, thinking they’re entitled to that one free visit every year, and walking out being billed for a sick visit, blood labs, and more. Researchers estimate that Americans spend tens of millions, maybe hundreds of millions of dollars every year on services that are supposed to be free under the ACA. Dr. Yalda Jabbarpour, a family physician in the Washington, DC, area and medical director of the Robert Graham Center for Policy Studies, told me she still deals all the time with people’s confusion about what a preventive visit really means. “Every single time I’m in the clinic, this issue comes up with a patient. And it’s sad that it comes up,” Jabbarpour told me. “In my mind, the blame is not to be put on the patient. The blame is not to be put on the physician. Really, this points to a bigger system issue that we need to solve.” How could a seemingly simple promise of one free annual doctor’s visit result in a situation so convoluted that patients and doctors are still struggling with it nearly two decades later? And how might we fix it? Patients are getting surprise bills from their doctors — and they’re pissed off The goal of the ACA was to expand coverage and make sure health insurance would be comprehensive to actually help people stay healthy. As part of that project, the authors of the law added a mandate for insurers to cover those services, including an annual wellness exam. The problem is, they did not define what the parameters of that preventive visit actually were, said Alex Hoagland, a healthcare economist at the University of Toronto. “It didn’t establish a clear definition of…all the diagnosis codes and procedure codes and how frequently you get that combination within a year,” he said. “They don’t define what actually is preventive care and what’s not.” Do’s and don’t’s for a preventive visit: Topics that should be free to talk about: routine vaccinations, many cancer screenings, screenings for diabetes and cardiovascular health, contraception. Topics that could lead to you getting charged: chronic pain, prior medical problems, other physical and mental health symptoms (including depression). If you are a first-time visitor at a doctor’s office, you may also be charged a “new patient” fee. That has left each insurer to define a preventive visit on their own — and that’s where the perverse incentives that leave patients in a lurch begin. Preventive visits are supposed to be reserved strictly for screenings and talking about other preventive measures you can take to protect your long-term health, but you may get billed for an “office visit” or a “sick visit” if you talk about any specific symptom you’re experiencing, the same as if you had come in because you had the flu. Health insurers have an incentive to keep the definition of preventive care as narrow as possible, so they have to pay fewer claims without any contribution from the patient. At the same time, doctors want to be paid for the actual services that they are providing. If somebody does bring up a bigger health problem during a preventive visit, then the doctor reasonably wants to be paid accordingly. “I know, particularly in the healthcare space, it’s really popular to blame one party or another, and here I don’t think it’s a matter of corporate greed or physician incompetence or whatever,” Hoagland said. “It’s just a natural mismatch of incentives.” So the reality is that “one free doctor’s visit” sounds straightforward, but, in practice, it’s much more complicated. You as the patient might think of it as one visit, but in our fee-for-service healthcare system, where providers bill based on each specific thing they do, it’s not. The conversation about your vaccination may be free — but asking about your back pain is not. If you get blood tests ordered, that’s another line item. The list goes on. “It’s not like you walk into a doctor’s office and it’s just one thing that happens, right?” said Sabrina Corlette, co-director of the Center on Health Insurance Reforms at Georgetown University. “It’s multiple different things that are happening when you go into a doctor’s office.” Part of the problem may be that it’s one free visit. We Americans are consumers at heart: Tell us we’re going to get something for free and we want to take advantage of it. But having just one free visit may also lead to people bringing a laundry list of questions to that preventive visit, because they think of it as their only chance to ask everything of their doctor. That makes it easy for the discussion to tip over into a sick visit — and not only does that lead to a surprise bill, it can also crowd out the conversation about prevention that the visit is supposed to be focused on. “What ends up happening a lot…is that a patient comes in for their annual visit, and in their mind, that is their time to bring up every single thing that’s been happening during the year, because they see it as the free visit to bring up everything that’s happened during the year. For some patients, that takes up the entire visit,” Jabbarpour told me. “They leave, and it’s like, ‘Oh my god, we forgot to do all the screening things: the vaccinations, the cancer screenings, and the cardiovascular risk screening.’ And then something happens down the line because you never address those screenings.” A 2021 study by Hoagland and Paul Shafer, both of Boston University at the time, estimated that Americans with employer-sponsored insurance had in 2018 alone paid between $75 million and $219 million in medical bills that should have been free. They were more likely to be charged for things like contraception or cholesterol and diabetes screenings, with individuals sometimes paying hundreds of dollars for those services. Hoagland told me he had been billed for preventive visits because he has type 1 diabetes and the system automatically categorized his appointment as a diabetic visit. Earlier this year, he co-authored a study that found people with chronic conditions were more likely to be charged for preventive care. Corlette said that she too had recently been charged for what was supposed to be a preventive visit after she mentioned an issue as an aside. And these are folks who study health care for a living. “It was literally maybe a 10-second conversation where I would ask the doctor a question about something,” she said. “And that triggered it.” Colonoscopies are another dramatic example of how this issue plays out in real life; Corlette told me the procedure was one of the first services where this fuzzy line between prevention and treatment under the ACA became obvious. People go under for what is supposed to be a preventive colonoscopy. But then their doctor finds a polyp and decides to remove it — good clinical practice, but as a result, their patient could end up being charged thousands of dollars because the colonoscopy was no longer preventive once that polyp was snipped. “All of a sudden, that would trigger what the patient thought was a preventive service into a cost-sharing obligation,” Corlette said. “Colonoscopies can be thousands of dollars. That was when we were first like, ‘Oh, yeah, this is a more complicated area than I think the lawmakers that drafted this provision originally envisioned.’” How the US could fix our preventive visit headaches The ACA’s preventive visit promise was clearly well-intentioned and it’s worth remembering that, if you look in the aggregate, more Americans are getting more free preventive care than they did before the law was passed. The problem, as much as anything, is expectations: People think they’re entitled to a free visit and are understandably frustrated when they get billed for it. “The difference is before the Affordable Care Act, maybe they anticipated some kind of cost-sharing,” Hoagland said. “But after, they expect it to be free.” Sign up for the Good Medicine newsletter Our political wellness landscape has shifted: new leaders, shady science, contradictory advice, broken

US death row inmate survives execution attempt after two lethal injections

Oct 1, 2026

Global Endometrial Cancer Therapeutics Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 2023 – Market Research Report 2017

More News

Pilot stabs fellow pilot on flight to Israel before passengers intervene to stop attack

Second judge blocks Trump's $100,000 fee for new H-1B worker visas

Google announces Gemini 4 flagship AI model after months of delays

Nearly 1,000 children were abused at three Massachusetts dioceses, state probe finds

N. Korea's Kim vows to bring bilateral ties to 'new strategic level' in letter to Xi

Why are French students blocking their school entrances?

Israel's Netanyahu says co-pilot tried to crash Tel Aviv-bound plane

Four passengers to be awarded for heroism during apparent attempt to crash plane

You’re supposed to get one free doctor’s visit every year. So why are so many Americans being charged?

US death row inmate survives execution attempt after two lethal injections

Naomi Campbell wins legal bid to overturn charity ban

9 best facial massage tools to sculpt, tone and depuff, reviewed by a beauty editor

Recommended

Trump to unveil $200 billion investment in US projects by S. Korea, White House says

Republican committee chief urges 'heightened vigilance' over S. Korea-China ties: report

What to know about the terrifying FlyDubai flight forced to land in Saudi Arabia

US military says its withdrawal of troops from Iraq is complete

Pilot carrying Israelis stabbed co-pilot, apparently tried to crash: Netanyahu

US inflation rises below expectations in August; consumer spending robust

S&P 500, Nasdaq advance as soft inflation tempers Fed rate-hike bets

Joy mixed with fear as US forces quit Iraq leaving potential security vacuum

Russia sends nuclear warning to NATO as tensions rise in the Baltic

Pentagon creates 'Autowarcom' to expand AI and drone capabilities